ESC 365 - Lipoprotein (Lp) (a) does not predict recurrent cardiovascular events in patients with stable coronary heart disease: 13-Year follow-up of the KAROLA study

ESC Premium Access

Lipoprotein (Lp) (a) does not predict recurrent cardiovascular events in patients with stable coronary heart disease: 13-Year follow-up of the KAROLA study

Session: Lipoproteins and real life: what the randomized clinical trials do not show us

Topic: Epidemiology, lipids

Speaker: Professor W. Koenig (Munich, DE)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Wolfgang Koenig

German Heart Center of Munich, Munich (Germany)

24 presentations

0 follower

4 more presentations in this session

State of the art in lipoproteins: lessons from real life registries

Speaker: Professor B. Nordestgaard (Copenhagen, DK)

Utility of ApoB target over LDL-C and non-HDL-C targets: insights from the national health and nutrition examination survey (NHANES) 2011-2012

Speaker: Doctor S. Martin (Baltimore, US)

Decline over the years in the risk of cardiovascular events in patients with clinical manifest vascular disease is explained by change in cardiovascular risk factors and atherosclerotic burden.

Speaker: Mr G. Berkelmans (Utrecht, NL)

Future direction for research in lipids.

Speaker: Professor E. Bruckert (Paris, FR)

Access the full session

Lipoproteins and real life: what the randomized clinical trials do not show us

Speakers: Professor W. Koenig, Professor B. Nordestgaard, Doctor S. Martin, Mr G. Berkelmans, Professor E. Bruckert

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources